Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $500.04 USD
Change Today -13.46 / -2.62%
Volume 628.3K
REGN On Other Exchanges
As of 3:14 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Alfred G. Gilman M.D., Ph.D.

Co-Founder, Independent Director, Chairman of Corporate Governance & Compliance Committee and Member of Technology Committee,Regeneron Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 11 board members in 1 different organizations across 2 different industries.

See Board Relationships


Dr. Alfred G. Gilman, M.D., Ph.D. is a Co-Founder of Regeneron Pharmaceuticals, Inc. Dr. Gilman has been Raymond and Ellen Willie Professor of Molecular Neuropharmacology and Chairman of the Department of Pharmacology at The University of Texas Southwestern Medical Center at Dallas since 1981. He serves as an Executive Vice President for Academic Affairs and Provost, The University of Texas Southwestern Medical Center at Dallas. He has been the Dean of the University ...

Read Full Background

Corporate Headquarters*

777 Old Saw Mill River Road
Tarrytown, New York 10591

United States

Phone: 914-847-7000
Fax: --

Board Members Memberships*

Co-Founder, Independent Director, Chairman of Corporate Governance & Compliance Committee and Member of Technology Committee


Honors Degree 1990
The University of Chicago
BS 1962
Yale University
Honors Degree 1997
Yale University
PhD 1969
Case Western Reserve University
MD 1969
Case Western Reserve University
Honors Degree 1995
Case Western Reserve University
Honors Degree 1999
University of Miami

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$80,000
Total Calculated Compensation$1,769,032
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
REGN:US $500.04 USD -13.46


Jean-Jacques Bienaime MBAChairman and Chief Executive Officer
BioMarin Pharmaceutical Inc.
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
Herve Hoppenot Chief Executive Officer, President, Director and Member of Non-Management Stock Option Committee
Incyte Corporation
Nobuo Hanai Ph.D.Chief Executive Officer, President and Representative Director
Kyowa Hakko Kirin Co., Ltd.
Jean-Christophe Tellier Chief Executive Officer and Executive Director
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGENERON PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at